Fairmount Funds Management LLC is an institutional accredited investor leading private placements in the biotechnology sector. The company focuses on strategic investments to support innovative therapeutic developments, with a recent notable participation in funding a robust pipeline of antibody therapeutics for inflammatory bowel disease.
Recent Transactions involving Fairmount Funds Management
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics |
Spyre Therapeutics |
Aeglea BioTherapeutics |
EcoR1 CapitalFairmount Funds ManagementVenrock Healthcare Capital PartnersCommodore CapitalPerceptive AdvisorsRTW InvestmentsCormorant Asset ManagementDriehaus Capital ManagementSurveyor CapitalWellington Management CompanyUndisclosed Institutional InvestorsFidelity Management and ResearchRA Capital ManagementDeepTrack Capital |
Biotechnology Research |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →